✦ LIBER ✦

Current status of biomarkers in head and neck cancer

✍ Scribed by Steven S. Chang; Joseph Califano

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 72 KB
Volume: 97
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathology reporting in head and neck can

Pathology reporting in head and neck cancer—Snapshot of current status

✍ Bronwyn King; June Corry 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract ## Background Currently there is no standardized head and neck pathology reporting system in Victoria, Australia. The aim of this study was to document deficiencies in head and neck pathology reports at our institution. ## Methods The pathology reports of all patients with head and n

Current status of FDG-PET for head and n

Current status of FDG-PET for head and neck cancer

✍ Richard J. Wong 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

## Abstract 18‐FDG‐PET has utility for the identification of the unknown primary head and neck squamous carcinoma, distant metastases or second primary carcinomas, and recurrent HNSCC in the post‐treatment setting. PET has a high negative predictive value in the detection of recurrent HNSCC. Standa

Head and neck cancer : Proteomic advance

Head and neck cancer : Proteomic advances and biomarker achievements

✍ Taia Maria Berto Rezende; Mirna de Souza Freire; Octávio Luiz Franco 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Workshop report: Organ preservation stra

Workshop report: Organ preservation strategies in advanced head and neck cancer—Current status and future directions

✍ Gregory T. Wolf; Arlene Forastiere; Kian Ang; Bruce Brockstein; Barbara Conley; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Proteomic identification of serum biomar

Proteomic identification of serum biomarkers for head and neck cancer surveillance

✍ Christine G. Gourin; Wenbo Zhi; Bao-Ling Adam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract ## Objectives/Hypothesis: Serum protein profiling by SELDI‐TOF‐MS distinguishes pretreatment and post‐treatment samples from patients with head and neck squamous cell cancer (HNSCC) by disease status (disease‐free or recurrence) with a high degree of sensitivity and specificity. We sou

Nuclear receptors in head and neck cance

Nuclear receptors in head and neck cancer: current knowledge and perspectives

✍ Andrea Schweitzer; Shirley K. Knauer; Roland H. Stauber 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 430 KB

## Abstract Disease management of head and neck cancer has improved significantly. However, a high rate of early recurrences and metastasis still counteract improvement of long‐term survival. Hence, the quest for molecular mechanisms and key regulatory factors exploitable by targeted therapies is s